nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—PRDX5—embryo—Alzheimer's disease	0.0232	0.149	CbGeAlD
Auranofin—PRDX5—forebrain—Alzheimer's disease	0.0205	0.132	CbGeAlD
Auranofin—PRDX5—telencephalon—Alzheimer's disease	0.0189	0.121	CbGeAlD
Auranofin—IKBKB—embryo—Alzheimer's disease	0.0137	0.0884	CbGeAlD
Auranofin—IKBKB—telencephalon—Alzheimer's disease	0.0112	0.0719	CbGeAlD
Auranofin—PRDX5—nervous system—Alzheimer's disease	0.0111	0.0716	CbGeAlD
Auranofin—PRDX5—central nervous system—Alzheimer's disease	0.0107	0.069	CbGeAlD
Auranofin—PRDX5—cerebellum—Alzheimer's disease	0.0105	0.0674	CbGeAlD
Auranofin—Hepatic enzyme increased—Galantamine—Alzheimer's disease	0.00936	0.0267	CcSEcCtD
Auranofin—Gingivitis—Donepezil—Alzheimer's disease	0.00874	0.0249	CcSEcCtD
Auranofin—Melaena—Galantamine—Alzheimer's disease	0.00864	0.0246	CcSEcCtD
Auranofin—PRDX5—brain—Alzheimer's disease	0.00852	0.0548	CbGeAlD
Auranofin—Gingivitis—Memantine—Alzheimer's disease	0.00793	0.0226	CcSEcCtD
Auranofin—Gingivitis—Rivastigmine—Alzheimer's disease	0.00776	0.0221	CcSEcCtD
Auranofin—Melaena—Donepezil—Alzheimer's disease	0.0067	0.0191	CcSEcCtD
Auranofin—Glossitis—Rivastigmine—Alzheimer's disease	0.00661	0.0188	CcSEcCtD
Auranofin—IKBKB—nervous system—Alzheimer's disease	0.0066	0.0424	CbGeAlD
Auranofin—Hepatic enzyme increased—Memantine—Alzheimer's disease	0.00658	0.0188	CcSEcCtD
Auranofin—IKBKB—central nervous system—Alzheimer's disease	0.00635	0.0408	CbGeAlD
Auranofin—IKBKB—cerebellum—Alzheimer's disease	0.00621	0.0399	CbGeAlD
Auranofin—Melaena—Memantine—Alzheimer's disease	0.00608	0.0173	CcSEcCtD
Auranofin—Melaena—Rivastigmine—Alzheimer's disease	0.00595	0.017	CcSEcCtD
Auranofin—Dysphagia—Galantamine—Alzheimer's disease	0.00555	0.0158	CcSEcCtD
Auranofin—IKBKB—brain—Alzheimer's disease	0.00504	0.0324	CbGeAlD
Auranofin—Weight decreased—Galantamine—Alzheimer's disease	0.00502	0.0143	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Donepezil—Alzheimer's disease	0.00498	0.0142	CcSEcCtD
Auranofin—Neuropathy peripheral—Galantamine—Alzheimer's disease	0.00485	0.0138	CcSEcCtD
Auranofin—Haematuria—Galantamine—Alzheimer's disease	0.00472	0.0135	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Memantine—Alzheimer's disease	0.00452	0.0129	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Rivastigmine—Alzheimer's disease	0.00442	0.0126	CcSEcCtD
Auranofin—Dysphagia—Donepezil—Alzheimer's disease	0.0043	0.0123	CcSEcCtD
Auranofin—Visual impairment—Galantamine—Alzheimer's disease	0.00428	0.0122	CcSEcCtD
Auranofin—Eosinophilia—Donepezil—Alzheimer's disease	0.00426	0.0121	CcSEcCtD
Auranofin—Eye disorder—Galantamine—Alzheimer's disease	0.00415	0.0118	CcSEcCtD
Auranofin—Dysphagia—Memantine—Alzheimer's disease	0.00391	0.0111	CcSEcCtD
Auranofin—Weight decreased—Donepezil—Alzheimer's disease	0.00389	0.0111	CcSEcCtD
Auranofin—Dysphagia—Rivastigmine—Alzheimer's disease	0.00382	0.0109	CcSEcCtD
Auranofin—Flatulence—Galantamine—Alzheimer's disease	0.00381	0.0109	CcSEcCtD
Auranofin—Dysgeusia—Galantamine—Alzheimer's disease	0.00379	0.0108	CcSEcCtD
Auranofin—Jaundice—Donepezil—Alzheimer's disease	0.00374	0.0107	CcSEcCtD
Auranofin—Conjunctivitis—Donepezil—Alzheimer's disease	0.00373	0.0106	CcSEcCtD
Auranofin—Pancytopenia—Memantine—Alzheimer's disease	0.00371	0.0106	CcSEcCtD
Auranofin—Haematuria—Donepezil—Alzheimer's disease	0.00366	0.0104	CcSEcCtD
Auranofin—Neutropenia—Memantine—Alzheimer's disease	0.00365	0.0104	CcSEcCtD
Auranofin—Anaemia—Galantamine—Alzheimer's disease	0.00358	0.0102	CcSEcCtD
Auranofin—Weight decreased—Memantine—Alzheimer's disease	0.00353	0.0101	CcSEcCtD
Auranofin—Weight decreased—Rivastigmine—Alzheimer's disease	0.00346	0.00986	CcSEcCtD
Auranofin—Neuropathy peripheral—Memantine—Alzheimer's disease	0.00341	0.00973	CcSEcCtD
Auranofin—Conjunctivitis—Memantine—Alzheimer's disease	0.00339	0.00965	CcSEcCtD
Auranofin—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.00334	0.00952	CcSEcCtD
Auranofin—Haematuria—Memantine—Alzheimer's disease	0.00332	0.00947	CcSEcCtD
Auranofin—Visual impairment—Donepezil—Alzheimer's disease	0.00332	0.00946	CcSEcCtD
Auranofin—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.00331	0.00944	CcSEcCtD
Auranofin—Agranulocytosis—Memantine—Alzheimer's disease	0.00325	0.00927	CcSEcCtD
Auranofin—Haematuria—Rivastigmine—Alzheimer's disease	0.00325	0.00926	CcSEcCtD
Auranofin—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00309	0.00881	CcSEcCtD
Auranofin—Alopecia—Donepezil—Alzheimer's disease	0.00304	0.00868	CcSEcCtD
Auranofin—Visual impairment—Memantine—Alzheimer's disease	0.00301	0.00859	CcSEcCtD
Auranofin—Anorexia—Galantamine—Alzheimer's disease	0.00301	0.00858	CcSEcCtD
Auranofin—Flatulence—Donepezil—Alzheimer's disease	0.00295	0.00842	CcSEcCtD
Auranofin—Visual impairment—Rivastigmine—Alzheimer's disease	0.00295	0.00841	CcSEcCtD
Auranofin—ALB—brain—Alzheimer's disease	0.00294	0.0189	CbGeAlD
Auranofin—Dysgeusia—Donepezil—Alzheimer's disease	0.00294	0.00837	CcSEcCtD
Auranofin—Eye disorder—Memantine—Alzheimer's disease	0.00292	0.00833	CcSEcCtD
Auranofin—Eye disorder—Rivastigmine—Alzheimer's disease	0.00286	0.00815	CcSEcCtD
Auranofin—Dyspepsia—Galantamine—Alzheimer's disease	0.00278	0.00792	CcSEcCtD
Auranofin—Anaemia—Donepezil—Alzheimer's disease	0.00277	0.0079	CcSEcCtD
Auranofin—Alopecia—Memantine—Alzheimer's disease	0.00276	0.00788	CcSEcCtD
Auranofin—Decreased appetite—Galantamine—Alzheimer's disease	0.00274	0.00782	CcSEcCtD
Auranofin—Alopecia—Rivastigmine—Alzheimer's disease	0.0027	0.00771	CcSEcCtD
Auranofin—Constipation—Galantamine—Alzheimer's disease	0.0027	0.0077	CcSEcCtD
Auranofin—Flatulence—Memantine—Alzheimer's disease	0.00268	0.00765	CcSEcCtD
Auranofin—Dysgeusia—Memantine—Alzheimer's disease	0.00267	0.0076	CcSEcCtD
Auranofin—Flatulence—Rivastigmine—Alzheimer's disease	0.00262	0.00748	CcSEcCtD
Auranofin—Dysgeusia—Rivastigmine—Alzheimer's disease	0.00261	0.00744	CcSEcCtD
Auranofin—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00258	0.00736	CcSEcCtD
Auranofin—Anaemia—Memantine—Alzheimer's disease	0.00252	0.00717	CcSEcCtD
Auranofin—Abdominal pain—Galantamine—Alzheimer's disease	0.0025	0.00712	CcSEcCtD
Auranofin—Anaemia—Rivastigmine—Alzheimer's disease	0.00246	0.00702	CcSEcCtD
Auranofin—Leukopenia—Memantine—Alzheimer's disease	0.00244	0.00695	CcSEcCtD
Auranofin—Thrombocytopenia—Donepezil—Alzheimer's disease	0.0024	0.00683	CcSEcCtD
Auranofin—Anorexia—Donepezil—Alzheimer's disease	0.00233	0.00665	CcSEcCtD
Auranofin—Thrombocytopenia—Memantine—Alzheimer's disease	0.00218	0.0062	CcSEcCtD
Auranofin—Diarrhoea—Galantamine—Alzheimer's disease	0.00216	0.00616	CcSEcCtD
Auranofin—Dyspepsia—Donepezil—Alzheimer's disease	0.00215	0.00614	CcSEcCtD
Auranofin—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.00213	0.00607	CcSEcCtD
Auranofin—Decreased appetite—Donepezil—Alzheimer's disease	0.00213	0.00606	CcSEcCtD
Auranofin—Anorexia—Memantine—Alzheimer's disease	0.00212	0.00604	CcSEcCtD
Auranofin—Constipation—Donepezil—Alzheimer's disease	0.00209	0.00597	CcSEcCtD
Auranofin—Anorexia—Rivastigmine—Alzheimer's disease	0.00207	0.00591	CcSEcCtD
Auranofin—Vomiting—Galantamine—Alzheimer's disease	0.00201	0.00572	CcSEcCtD
Auranofin—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.002	0.0057	CcSEcCtD
Auranofin—Rash—Galantamine—Alzheimer's disease	0.00199	0.00568	CcSEcCtD
Auranofin—Dermatitis—Galantamine—Alzheimer's disease	0.00199	0.00567	CcSEcCtD
Auranofin—Dyspepsia—Memantine—Alzheimer's disease	0.00196	0.00558	CcSEcCtD
Auranofin—Urticaria—Donepezil—Alzheimer's disease	0.00194	0.00554	CcSEcCtD
Auranofin—Abdominal pain—Donepezil—Alzheimer's disease	0.00193	0.00551	CcSEcCtD
Auranofin—Decreased appetite—Memantine—Alzheimer's disease	0.00193	0.00551	CcSEcCtD
Auranofin—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00191	0.00545	CcSEcCtD
Auranofin—Constipation—Memantine—Alzheimer's disease	0.0019	0.00542	CcSEcCtD
Auranofin—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00189	0.00539	CcSEcCtD
Auranofin—Nausea—Galantamine—Alzheimer's disease	0.00188	0.00535	CcSEcCtD
Auranofin—Constipation—Rivastigmine—Alzheimer's disease	0.00186	0.0053	CcSEcCtD
Auranofin—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00182	0.00518	CcSEcCtD
Auranofin—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.00178	0.00507	CcSEcCtD
Auranofin—Urticaria—Memantine—Alzheimer's disease	0.00176	0.00503	CcSEcCtD
Auranofin—Abdominal pain—Memantine—Alzheimer's disease	0.00176	0.00501	CcSEcCtD
Auranofin—Pruritus—Donepezil—Alzheimer's disease	0.00173	0.00494	CcSEcCtD
Auranofin—Urticaria—Rivastigmine—Alzheimer's disease	0.00173	0.00492	CcSEcCtD
Auranofin—Abdominal pain—Rivastigmine—Alzheimer's disease	0.00172	0.0049	CcSEcCtD
Auranofin—Diarrhoea—Donepezil—Alzheimer's disease	0.00167	0.00477	CcSEcCtD
Auranofin—Pruritus—Memantine—Alzheimer's disease	0.00157	0.00448	CcSEcCtD
Auranofin—Vomiting—Donepezil—Alzheimer's disease	0.00156	0.00444	CcSEcCtD
Auranofin—Rash—Donepezil—Alzheimer's disease	0.00154	0.0044	CcSEcCtD
Auranofin—Dermatitis—Donepezil—Alzheimer's disease	0.00154	0.00439	CcSEcCtD
Auranofin—Pruritus—Rivastigmine—Alzheimer's disease	0.00154	0.00438	CcSEcCtD
Auranofin—Diarrhoea—Memantine—Alzheimer's disease	0.00152	0.00433	CcSEcCtD
Auranofin—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00149	0.00424	CcSEcCtD
Auranofin—Nausea—Donepezil—Alzheimer's disease	0.00145	0.00414	CcSEcCtD
Auranofin—Vomiting—Memantine—Alzheimer's disease	0.00141	0.00403	CcSEcCtD
Auranofin—Rash—Memantine—Alzheimer's disease	0.0014	0.00399	CcSEcCtD
Auranofin—Dermatitis—Memantine—Alzheimer's disease	0.0014	0.00399	CcSEcCtD
Auranofin—Vomiting—Rivastigmine—Alzheimer's disease	0.00138	0.00394	CcSEcCtD
Auranofin—Rash—Rivastigmine—Alzheimer's disease	0.00137	0.00391	CcSEcCtD
Auranofin—Dermatitis—Rivastigmine—Alzheimer's disease	0.00137	0.0039	CcSEcCtD
Auranofin—Nausea—Memantine—Alzheimer's disease	0.00132	0.00376	CcSEcCtD
Auranofin—Nausea—Rivastigmine—Alzheimer's disease	0.00129	0.00368	CcSEcCtD
Auranofin—ALB—Hemostasis—CDK5—Alzheimer's disease	0.000227	0.00046	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—MAPK8—Alzheimer's disease	0.000227	0.000459	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CTSB—Alzheimer's disease	0.000226	0.000457	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—INPP5D—Alzheimer's disease	0.000225	0.000456	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—MAPK8—Alzheimer's disease	0.000224	0.000454	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—TP53—Alzheimer's disease	0.000222	0.00045	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PPP3CA—Alzheimer's disease	0.000221	0.000448	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—APOD—Alzheimer's disease	0.000221	0.000447	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—MAPK8—Alzheimer's disease	0.000221	0.000447	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—AKT1—Alzheimer's disease	0.000219	0.000443	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—CALM1—Alzheimer's disease	0.000219	0.000443	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PIN1—Alzheimer's disease	0.000217	0.000439	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CTSB—Alzheimer's disease	0.000217	0.000439	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CTSD—Alzheimer's disease	0.000216	0.000436	CbGpPWpGaD
Auranofin—IKBKB—MyD88 cascade initiated on plasma membrane—IL6—Alzheimer's disease	0.000215	0.000435	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—Alzheimer's disease	0.000213	0.000431	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—IL1B—Alzheimer's disease	0.000213	0.00043	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—CASP3—Alzheimer's disease	0.000212	0.00043	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—GAB2—Alzheimer's disease	0.000212	0.000429	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—TNF—Alzheimer's disease	0.000212	0.000428	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—GSK3A—Alzheimer's disease	0.00021	0.000425	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CR1—Alzheimer's disease	0.000209	0.000424	CbGpPWpGaD
Auranofin—IKBKB—MyD88 dependent cascade initiated on endosome—IL6—Alzheimer's disease	0.000209	0.000423	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—APP—Alzheimer's disease	0.000207	0.000418	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CFH—Alzheimer's disease	0.000206	0.000417	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—IL6—Alzheimer's disease	0.000205	0.000415	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—MAPK8—Alzheimer's disease	0.000203	0.00041	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—PTGS2—Alzheimer's disease	0.000203	0.00041	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—GSK3A—Alzheimer's disease	0.000202	0.000409	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—IL6—Alzheimer's disease	0.000202	0.000408	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—IL6—Alzheimer's disease	0.000202	0.000408	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—AKT1—Alzheimer's disease	0.0002	0.000405	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—AKT1—Alzheimer's disease	0.0002	0.000405	CbGpPWpGaD
Auranofin—IKBKB—MyD88:Mal cascade initiated on plasma membrane—IL6—Alzheimer's disease	0.000198	0.000401	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—MAPK8—Alzheimer's disease	0.000195	0.000395	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TTR—Alzheimer's disease	0.000192	0.000389	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—SOD1—Alzheimer's disease	0.000192	0.000388	CbGpPWpGaD
Auranofin—IKBKB—MyD88-independent cascade—IL6—Alzheimer's disease	0.00019	0.000385	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—AKT1—Alzheimer's disease	0.000189	0.000383	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—GSK3B—Alzheimer's disease	0.000189	0.000382	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—IL1B—Alzheimer's disease	0.000188	0.000382	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—CREB1—Alzheimer's disease	0.000187	0.000379	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—MAPK8—Alzheimer's disease	0.000187	0.000379	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—AKT1—Alzheimer's disease	0.000186	0.000376	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—IL6—Alzheimer's disease	0.000186	0.000376	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PVRL2—Alzheimer's disease	0.000184	0.000373	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—IGF2—Alzheimer's disease	0.000182	0.000369	CbGpPWpGaD
Auranofin—ALB—Hemostasis—CLU—Alzheimer's disease	0.00018	0.000364	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—Alzheimer's disease	0.000179	0.000364	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—AKT1—Alzheimer's disease	0.000178	0.000361	CbGpPWpGaD
Auranofin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—Alzheimer's disease	0.000177	0.000359	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—IL6—Alzheimer's disease	0.000177	0.000359	CbGpPWpGaD
Auranofin—ALB—Metabolism—DHCR24—Alzheimer's disease	0.000175	0.000355	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—VEGFA—Alzheimer's disease	0.000172	0.000349	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—TNF—Alzheimer's disease	0.000172	0.000349	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—AKT1—Alzheimer's disease	0.000171	0.000347	CbGpPWpGaD
Auranofin—IKBKB—Activated TLR4 signalling—IL6—Alzheimer's disease	0.000171	0.000346	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—IL6—Alzheimer's disease	0.000171	0.000346	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PYY—Alzheimer's disease	0.000168	0.00034	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—S100B—Alzheimer's disease	0.000168	0.00034	CbGpPWpGaD
Auranofin—IKBKB—Immune System—EIF2AK2—Alzheimer's disease	0.000167	0.000339	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TGFB1—Alzheimer's disease	0.000165	0.000335	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PRKCG—Alzheimer's disease	0.000164	0.000332	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—Alzheimer's disease	0.000164	0.000332	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	0.000163	0.000331	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6—Alzheimer's disease	0.000161	0.000326	CbGpPWpGaD
Auranofin—ALB—Hemostasis—A2M—Alzheimer's disease	0.00016	0.000324	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—TGFB1—Alzheimer's disease	0.000158	0.00032	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TNF—Alzheimer's disease	0.000154	0.000312	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—TP53—Alzheimer's disease	0.000152	0.000307	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—Alzheimer's disease	0.000151	0.000305	CbGpPWpGaD
Auranofin—ALB—Metabolism—CA4—Alzheimer's disease	0.000149	0.000302	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MEF2C—Alzheimer's disease	0.000147	0.000298	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CDK5—Alzheimer's disease	0.000146	0.000295	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	0.000146	0.000295	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—AGER—Alzheimer's disease	0.000146	0.000295	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—Alzheimer's disease	0.000145	0.000293	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PRKCG—Alzheimer's disease	0.000144	0.000292	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—IL6—Alzheimer's disease	0.000143	0.00029	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—CALM1—Alzheimer's disease	0.000142	0.000288	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL1B—Alzheimer's disease	0.000141	0.000286	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HTR6—Alzheimer's disease	0.00014	0.000284	CbGpPWpGaD
Auranofin—ALB—Metabolism—GAPDHS—Alzheimer's disease	0.00014	0.000284	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—IL6—Alzheimer's disease	0.000139	0.000281	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—CASP3—Alzheimer's disease	0.000139	0.000281	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.000139	0.000281	CbGpPWpGaD
Auranofin—ALB—Hemostasis—INPP5D—Alzheimer's disease	0.000138	0.000279	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—TNF—Alzheimer's disease	0.000137	0.000277	CbGpPWpGaD
Auranofin—IKBKB—Immune System—INPP5D—Alzheimer's disease	0.000137	0.000276	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TF—Alzheimer's disease	0.000136	0.000276	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TP53—Alzheimer's disease	0.000136	0.000275	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—AKT1—Alzheimer's disease	0.000134	0.000271	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—F2—Alzheimer's disease	0.000133	0.00027	CbGpPWpGaD
Auranofin—ALB—Metabolism—ATP5A1—Alzheimer's disease	0.000133	0.000269	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CTSB—Alzheimer's disease	0.000131	0.000266	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CTSD—Alzheimer's disease	0.000131	0.000265	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—AKT1—Alzheimer's disease	0.00013	0.000263	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PPP3CA—Alzheimer's disease	0.000129	0.000261	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—MAPK8—Alzheimer's disease	0.000127	0.000258	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PSENEN—Alzheimer's disease	0.000127	0.000258	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PTK2B—Alzheimer's disease	0.000127	0.000257	CbGpPWpGaD
Auranofin—ALB—Metabolism—PLD3—Alzheimer's disease	0.000127	0.000257	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	0.000127	0.000257	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—APH1A—Alzheimer's disease	0.000126	0.000254	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	0.000125	0.000254	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CALM1—Alzheimer's disease	0.000125	0.000253	CbGpPWpGaD
Auranofin—ALB—Hemostasis—GAB2—Alzheimer's disease	0.000124	0.000252	CbGpPWpGaD
Auranofin—IKBKB—Immune System—GAB2—Alzheimer's disease	0.000123	0.00025	CbGpPWpGaD
Auranofin—IKBKB—Immune System—GSK3A—Alzheimer's disease	0.000122	0.000248	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NCSTN—Alzheimer's disease	0.000122	0.000248	CbGpPWpGaD
Auranofin—ALB—Metabolism—HSD17B10—Alzheimer's disease	0.000121	0.000246	CbGpPWpGaD
Auranofin—ALB—Hemostasis—APP—Alzheimer's disease	0.000121	0.000246	CbGpPWpGaD
Auranofin—IKBKB—Immune System—APP—Alzheimer's disease	0.00012	0.000244	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CALM1—Alzheimer's disease	0.00012	0.000243	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—AKT1—Alzheimer's disease	0.000119	0.000242	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—Alzheimer's disease	0.000119	0.000242	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—LRP1—Alzheimer's disease	0.000119	0.000241	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	0.000119	0.00024	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—TF—Alzheimer's disease	0.000118	0.000239	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP46A1—Alzheimer's disease	0.000117	0.000237	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—IGF1—Alzheimer's disease	0.000117	0.000237	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GFAP—Alzheimer's disease	0.000116	0.000236	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GAL—Alzheimer's disease	0.000116	0.000236	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—AKT1—Alzheimer's disease	0.000115	0.000234	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—AKT1—Alzheimer's disease	0.000115	0.000233	CbGpPWpGaD
Auranofin—ALB—Metabolism—ND1—Alzheimer's disease	0.000113	0.000229	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	0.00011	0.000224	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—IL6—Alzheimer's disease	0.00011	0.000223	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—Alzheimer's disease	0.00011	0.000223	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—GSK3B—Alzheimer's disease	0.000108	0.000218	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CREB1—Alzheimer's disease	0.000107	0.000216	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—GSK3B—Alzheimer's disease	0.000103	0.000209	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—A2M—Alzheimer's disease	0.000103	0.000208	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CREB1—Alzheimer's disease	0.000103	0.000208	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—AKT1—Alzheimer's disease	0.000102	0.000206	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	0.000101	0.000204	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PSEN2—Alzheimer's disease	9.94e-05	0.000201	CbGpPWpGaD
Auranofin—ALB—Hemostasis—SOD1—Alzheimer's disease	9.88e-05	0.0002	CbGpPWpGaD
Auranofin—IKBKB—Immune System—S100B—Alzheimer's disease	9.78e-05	0.000198	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IGF2—Alzheimer's disease	9.39e-05	0.00019	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NPY—Alzheimer's disease	9.15e-05	0.000185	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IAPP—Alzheimer's disease	9.09e-05	0.000184	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—BCL2—Alzheimer's disease	8.96e-05	0.000182	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL1A—Alzheimer's disease	8.85e-05	0.000179	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CRH—Alzheimer's disease	8.83e-05	0.000179	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	8.7e-05	0.000176	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MEF2C—Alzheimer's disease	8.56e-05	0.000173	CbGpPWpGaD
Auranofin—IKBKB—Immune System—AGER—Alzheimer's disease	8.48e-05	0.000172	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PRKCG—Alzheimer's disease	8.46e-05	0.000171	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PRKCG—Alzheimer's disease	8.4e-05	0.00017	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NPS—Alzheimer's disease	8.37e-05	0.000169	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PPP3CA—Alzheimer's disease	8.33e-05	0.000169	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL6—Alzheimer's disease	8.27e-05	0.000168	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	8.24e-05	0.000167	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PTK2B—Alzheimer's disease	8.2e-05	0.000166	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—IL6—Alzheimer's disease	8.13e-05	0.000165	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SST—Alzheimer's disease	7.98e-05	0.000162	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GAB2—Alzheimer's disease	7.98e-05	0.000162	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NTRK2—Alzheimer's disease	7.98e-05	0.000162	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	7.92e-05	0.00016	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GSK3A—Alzheimer's disease	7.91e-05	0.00016	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—APP—Alzheimer's disease	7.78e-05	0.000158	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—VEGFA—Alzheimer's disease	7.64e-05	0.000155	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—AKT1—Alzheimer's disease	7.5e-05	0.000152	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PLAU—Alzheimer's disease	7.4e-05	0.00015	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PLCB1—Alzheimer's disease	7.34e-05	0.000149	CbGpPWpGaD
Auranofin—ALB—Hemostasis—CALM1—Alzheimer's disease	7.32e-05	0.000148	CbGpPWpGaD
Auranofin—ALB—Metabolism—TPI1—Alzheimer's disease	7.28e-05	0.000147	CbGpPWpGaD
Auranofin—ALB—Metabolism—CHAT—Alzheimer's disease	7.28e-05	0.000147	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MAPK8—Alzheimer's disease	7.26e-05	0.000147	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CALM1—Alzheimer's disease	7.26e-05	0.000147	CbGpPWpGaD
Auranofin—ALB—Hemostasis—CAV1—Alzheimer's disease	7.23e-05	0.000146	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—TGFB1—Alzheimer's disease	7.01e-05	0.000142	CbGpPWpGaD
Auranofin—ALB—Metabolism—MAOB—Alzheimer's disease	6.98e-05	0.000141	CbGpPWpGaD
Auranofin—ALB—Hemostasis—F2—Alzheimer's disease	6.88e-05	0.000139	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NGFR—Alzheimer's disease	6.85e-05	0.000139	CbGpPWpGaD
Auranofin—ALB—Hemostasis—NOS2—Alzheimer's disease	6.8e-05	0.000138	CbGpPWpGaD
Auranofin—ALB—Metabolism—GAPDH—Alzheimer's disease	6.72e-05	0.000136	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ADAM10—Alzheimer's disease	6.69e-05	0.000135	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	6.64e-05	0.000134	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	6.58e-05	0.000133	CbGpPWpGaD
Auranofin—ALB—Metabolism—A2M—Alzheimer's disease	6.49e-05	0.000131	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—S100B—Alzheimer's disease	6.32e-05	0.000128	CbGpPWpGaD
Auranofin—IKBKB—Immune System—GSK3B—Alzheimer's disease	6.27e-05	0.000127	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CREB1—Alzheimer's disease	6.22e-05	0.000126	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IGF1—Alzheimer's disease	6.03e-05	0.000122	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IGF2—Alzheimer's disease	6.02e-05	0.000122	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IGF1R—Alzheimer's disease	5.82e-05	0.000118	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	5.78e-05	0.000117	CbGpPWpGaD
Auranofin—ALB—Metabolism—ACHE—Alzheimer's disease	5.64e-05	0.000114	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—LPL—Alzheimer's disease	5.58e-05	0.000113	CbGpPWpGaD
Auranofin—ALB—Metabolism—INPP5D—Alzheimer's disease	5.58e-05	0.000113	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MEF2C—Alzheimer's disease	5.53e-05	0.000112	CbGpPWpGaD
Auranofin—ALB—Hemostasis—NOS3—Alzheimer's disease	5.46e-05	0.000111	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PRKCG—Alzheimer's disease	5.43e-05	0.00011	CbGpPWpGaD
Auranofin—ALB—Metabolism—ENO1—Alzheimer's disease	5.29e-05	0.000107	CbGpPWpGaD
Auranofin—ALB—Metabolism—PTGS1—Alzheimer's disease	5.29e-05	0.000107	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NGF—Alzheimer's disease	5.29e-05	0.000107	CbGpPWpGaD
Auranofin—IKBKB—Immune System—BCL2—Alzheimer's disease	5.22e-05	0.000106	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP2D6—Alzheimer's disease	5.19e-05	0.000105	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCR5—Alzheimer's disease	5.14e-05	0.000104	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HTR2A—Alzheimer's disease	5.03e-05	0.000102	CbGpPWpGaD
Auranofin—ALB—Metabolism—BCHE—Alzheimer's disease	4.92e-05	9.96e-05	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	4.87e-05	9.87e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CALM1—Alzheimer's disease	4.7e-05	9.51e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—APOE—Alzheimer's disease	4.68e-05	9.48e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—LEP—Alzheimer's disease	4.68e-05	9.48e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PLCB1—Alzheimer's disease	4.64e-05	9.39e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IL6—Alzheimer's disease	4.64e-05	9.39e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CAV1—Alzheimer's disease	4.64e-05	9.39e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL1B—Alzheimer's disease	4.61e-05	9.34e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.55e-05	9.22e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—ABCA1—Alzheimer's disease	4.5e-05	9.11e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ESR1—Alzheimer's disease	4.47e-05	9.05e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—F2—Alzheimer's disease	4.41e-05	8.94e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NOTCH1—Alzheimer's disease	4.32e-05	8.75e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—AKT1—Alzheimer's disease	4.28e-05	8.67e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MAPK8—Alzheimer's disease	4.23e-05	8.57e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—AKT1—Alzheimer's disease	4.11e-05	8.32e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GSK3B—Alzheimer's disease	4.05e-05	8.21e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CREB1—Alzheimer's disease	4.02e-05	8.14e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—INS—Alzheimer's disease	4e-05	8.1e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—VEGFA—Alzheimer's disease	3.94e-05	7.97e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCL2—Alzheimer's disease	3.93e-05	7.97e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PPARGC1A—Alzheimer's disease	3.88e-05	7.85e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IGF1—Alzheimer's disease	3.87e-05	7.83e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—HMOX1—Alzheimer's disease	3.86e-05	7.81e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TGFB1—Alzheimer's disease	3.61e-05	7.32e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—LPL—Alzheimer's disease	3.53e-05	7.15e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NOS3—Alzheimer's disease	3.51e-05	7.1e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—MTHFR—Alzheimer's disease	3.18e-05	6.43e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CASP3—Alzheimer's disease	2.98e-05	6.03e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TP53—Alzheimer's disease	2.97e-05	6.02e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CALM1—Alzheimer's disease	2.97e-05	6.01e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—APOE—Alzheimer's disease	2.96e-05	5.99e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CAV1—Alzheimer's disease	2.93e-05	5.93e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MAPK8—Alzheimer's disease	2.74e-05	5.54e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL6—Alzheimer's disease	2.7e-05	5.47e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PPARG—Alzheimer's disease	2.58e-05	5.22e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—INS—Alzheimer's disease	2.53e-05	5.12e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—VEGFA—Alzheimer's disease	2.53e-05	5.11e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—AKT1—Alzheimer's disease	2.51e-05	5.09e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—AKT1—Alzheimer's disease	2.49e-05	5.05e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TGFB1—Alzheimer's disease	2.32e-05	4.69e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—NOS3—Alzheimer's disease	2.22e-05	4.49e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PTGS2—Alzheimer's disease	2.03e-05	4.1e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TP53—Alzheimer's disease	1.91e-05	3.86e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL6—Alzheimer's disease	1.75e-05	3.54e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AKT1—Alzheimer's disease	1.61e-05	3.26e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—AKT1—Alzheimer's disease	1.02e-05	2.06e-05	CbGpPWpGaD
